Underwriters exercise $918,750 portion of $3.04 million greenshoe
By Angela McDaniels
Tacoma, Wash., May 22 – Aldeyra Therapeutics, Inc. said the underwriters for its public offering of stock exercised their over-allotment option in part, increasing the size of the offering to $21.17 million.
As previously reported, the company priced $20.25 million of stock on May 8 with a $3.04 million greenshoe, of which $918,750 was exercised. Plans for the deal were announced April 20.
The price per share, $7.50, is a 9.2% discount to the May 7 closing share price of $8.26.
Cowen and Co., LLC and Canaccord Genuity Inc. were the bookrunners.
Proceeds will be used for research and development activities and for working capital and other general corporate purposes.
Aldeyra is a Lexington, Mass., biotechnology company.
| Issuer: | Aldeyra Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $21,168,750, increased from $20.25 million
|
| Shares: | 2,822,500
|
| Price: | $7.50
|
| Warrants: | No
|
| Bookrunners: | Cowen and Co., LLC and Canaccord Genuity Inc.
|
| Co-managers: | Janney Montgomery Scott LLC and Laidlaw & Co. (UK) Ltd.
|
| Announcement date: | April 20
|
| Pricing date: | May 8
|
| Settlement date: | May 13
|
| Stock symbol: | Nasdaq: ALDX
|
| Stock price: | $8.26 at close May 7
|
| Market capitalization: | $50.23 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
